Ameesh Divatia is co-Founder & CEO of Baffle, Inc., with a proven track record of turning innovative ideas into successful businesses.
Some estimate that 90% of the world’s data has been produced in the past two years alone. This proverbial tidal wave of information positions businesses to inform decisions that optimize operations, attract and retain customers, and create significant market differentiation. The challenge is how to make sense of data in multiple formats that emanate from disparate sources.
For data to provide value, it must flow through what is referred to as the analytics pipeline: the infrastructure used to collect, store and process data in an IT environment. In the analytics pipeline, unstructured data — such as emails, Excel spreadsheets, Word documents, presentations, instant messages, photos, audio and video — enters “upstream.” As data moves “downstream” toward the end of the pipeline, it is cleansed, organized and analyzed
SAN FRANCISCO, SACRAMENTO, SAN DIEGO, Calif. & WASHINGTON–(BUSINESS WIRE)–Oct 7, 2020–
California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, today released the 2020 California Life Sciences Sector Report, which shows that California’s life sciences sector directly employed 323,723 people, generated $191.6 billion in revenue, is projected to attract $6.5 billion in venture capital (VC) and received $4.5 billion in funding from the NIH. Produced with PwC US, the 2020 snapshot highlights the strength of California’s biomedical sector – the largest cluster in the world – as evidenced by significant increases in employment, earnings, graduating science and engineering PhDs, VC investment, and potential new drugs and medical devices in the pipeline.
Key Highlights from 2020 California Life Sciences Sector Report
4.0% increase in total life sciences jobs (up more than 12,000 from prior year), with companies directly employing 323,723 Californians – the most in
IP2 Accelerates CCS-enabled 4D-Proteomics™ with GPU-based Scalable Search Engine
IP2 Adds ‘Run & Done’ Real-Time Capabilities to timsTOF® Proteomics Systems
Bruker Corporation (Nasdaq: BRKR) announces the recent acquisition of the Integrated Proteomics Pipeline (IP2) search engine and proteomics workflow software platform. IP2 was developed by Integrated Proteomics Applications Inc, a company founded by leading proteomics researcher Professor John Yates III, together with Drs. Robin Park and Tao Xu. Financial details of the transaction were not disclosed.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200930005135/en/
Prof. John Yates III, The Scripps Research Institute (Photo: Business Wire)
This acquisition further enhances Bruker’s solutions for CCS-enabled 4D-Proteomics™ by adding fast, scalable and GPU-based search engine capabilities for faster data processing and full utilization of molecular collision cross sections (CCS). Benefits include greater data completeness and higher confidence in protein and PTM identification and quantification in unbiased ‘shot-gun’ proteomics. Bruker’s